Axonics, Inc. Common Stock
AXNX
AXNX was delisted on the 14th of November, 2024.
2 hedge funds and large institutions have $15.5M invested in Axonics, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 229 closing their positions.
99% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 229
99% less funds holding
Funds holding: 233 → 2 (-231)
100% less capital invested
Capital invested by funds: $3.54B → $15.5M (-$3.52B)
100% less funds holding in top 10
Funds holding in top 10: 20 → 0 (-20)
Top Buyers
| 1 |
TCA
Taconic Capital Advisors
New York
|
+$15.8M |
| 2 |
IA
IFP Advisors
Tampa,
Florida
|
+$70 |
Top Sellers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$352M |
| 2 |
BlackRock
New York
|
-$304M |
| 3 |
HI
HBK Investments
Dallas,
Texas
|
-$172M |
| 4 |
AAM
Alpine Associates Management
Palm Beach,
Florida
|
-$152M |
| 5 |
UOC
UBS O'Connor
Chicago,
Illinois
|
-$150M |
AXNX Hedge Fund Activity: Q4 2024 in Review
2 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in Axonics, Inc. Common Stock (AXNX) for Q4 2024, worth a combined $15.5M — down 100% from $3.54B a quarter earlier.
Sellers outnumbered buyers: 229 funds closed out of AXNX and 2 opened new positions — a net loss of 227 holders — while 0 trimmed existing stakes and 0 added.
The largest buyer was Taconic Capital Advisors, opening a new position worth an estimated $15.8M. The largest seller was Vanguard Group, exiting entirely with an estimated $352M sold.
- 2 institutional investors held Axonics, Inc. Common Stock (AXNX) as of Q4 2024, down from 233 in Q3 2024.
- Funds reported $15.5M of Axonics, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
- 2 funds opened new Axonics, Inc. Common Stock positions in Q4 2024 and 229 closed out, a net change of -227 holders.
- The largest Axonics, Inc. Common Stock buyer in Q4 2024 was Taconic Capital Advisors, an estimated $15.8M added.
- The largest Axonics, Inc. Common Stock seller in Q4 2024 was Vanguard Group, an estimated $352M sold.
Based on aggregated 13F filings for Q4 2024.